Save time and get answers to complex questions with AI chat
When oxcarbazepine patent expired?When will there be a generic loreev available?Patent expiry trametinib?Generic brand for latisse?Pramlintide fda approval date?
See the DrugPatentWatch profile for kesimpta
Kesimpta (ofatumumab) is manufactured by Samsung Bioepis Co., Ltd. at its manufacturing facilities in South Korea. This includes production at Samsung Bioepis’s plants in Incheon and/or other sites in South Korea used for biologics manufacturing. [1]
Kesimpta is developed by Novartis and produced through manufacturing partners. Samsung Bioepis is one of the key manufacturers associated with Kesimpta’s supply. [1]
The country of manufacture can vary by product lot and distribution channel, but the underlying manufacturing is tied to South Korea facilities associated with Samsung Bioepis. Checking the specific box label or package insert for a given lot is the most reliable way to confirm the exact manufacturing location. [1]
Other Questions About Kesimpta :